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Sex Steroids and the Free 
Hormone Hypothesis
In their research article published in 
the September 9, 2005 issue of Cell, 
Hammes et al. (2005) investigated the 
role of megalin (an endocytic receptor in 
a variety of tissues) and SHBG (sex hor-
mone binding globulin) on the cellular 
uptake of sex steroid hormones in mice. 
In plasma, androgens and estrogens 
can circulate bound tightly to SHBG, 
bound loosely to albumin, unbound, 
or free. Although oversimplified, the 
currently favored view—called the free 
hormone hypothesis—postulates that 
it is the free and albumin bound forms 
of sex steroid hormones that are avail-
able for diffusion out of capillaries and 
into cells, where they initiate an appro-
priate response. Hammes et al. (2005) 
report that megalin enables, and is 
crucial for, the internalization of sex 
steroids bound to SHBG, suggesting 
an alternative pathway for the uptake 
of sex steroid hormones. However, 
there are several important points that 
raise questions about the conclusions 
drawn from this study.
Hammes et al. (2005) used both 
an in vitro model, the BN16 cell line 
that expresses megalin, and an in vivo 
model, the megalin knockout mouse 
(Nykjaer et al., 1999), to examine the 
interactions among megalin, SHBG, 
and certain sex steroids. Mice lacking 
megalin are severely deficient in vitamin 
D, and this deficiency has been reported 
to be associated with impaired gonadal 
development and function (Kinuta et 
al., 2000). Thus, it is possible that it is 
a deficiency in vitamin D and not a lack 
of megalin that causes the reproductive 
abnormalities observed by Hammes et 
al. in their megalin knockout mice. Fur-
thermore, the adult mouse liver does 
not synthesize SHBG and there is no 
SHBG in adult mouse plasma (Janne et 
al., 1999). Thus, findings related to the 
importance of SHBG in the uptake of 
steroids and in steroid hormone action 
in this mouse model are unlikely to yield 
biologically relevant results. In addition, 
whereas the BN16 cell line expresses 
megalin, it does not express recep-tors for androgens and estrogens, 
calling into question the physiological 
relevance of studies on the uptake of 
steroid hormones in these cells.
There are several other concerns 
regarding this study. The authors ana-
lyzed the specificity of the megalin-
SHBG interaction both before and after 
denaturation of megalin (see Hammes 
et al., 2005, Figure 1A). Although SHBG 
does not bind to denatured megalin, the 
binding of megalin to denatured SHBG 
was not investigated. It is feasible that 
megalin, which is known to bind to a 
large variety of protein and nonprotein 
ligands (Christensen and Birn, 2002), 
may be able to bind biologically inactive 
125I-SHBG resulting in a misinterpreta-
tion of these experiments.
The authors ascertained the uptake 
of 3H-testosterone by BN16 cells from 
media containing SHBG (Figure 1C), 
but only after a 5 hr incubation. They 
did not chemically characterize the 
molecules that had incorporated the 
3H-label—it could have been incorpo-
rated into any number of metabolites of 
testosterone. In the absence of kinetic 
data, it is not clear whether other events 
confounded the interpretation of the 
results, such as rapid uptake of testo-
sterone with its subsequent release into 
the medium. Testosterone is known to 
rapidly enter cells in vitro and to be 
metabolized extensively; the metabo-
lites exist in cells and are released into 
the medium (Smith et al., 1994). When 
Hammes et al. (2005) incubated BN16 
cells with a 5-fold excess of SHBG (500 
nM) relative to 3H-testosterone, only 
11% of the 3H-label was associated with 
the cells (Figure 1C). Furthermore, the 
3H-compounds were not identified. If 
the suggestion by Hammes et al.—that 
sex steroid hormones bound to SHBG 
are taken up by cells with the help of 
megalin—were correct, then one would 
expect more than 11% uptake of the 
bound steroid. At zero time, essentially 
all of the 3H-testosterone is bound; thus 
the steroid uptake should have been 
roughly equal to the 40% uptake for 125I-Cell 124, FSHBG seen in a separate experiment 
(Figure 1B). The demonstration that 
the megalin antagonist RAP (receptor-
associated protein) almost totally blocks 
3H-testosterone uptake does not clarify 
this issue. One could argue that the 
high concentration of SHBG (500 nM) 
(Figure 1C) decreases its percentage 
uptake from the 40% demonstrated 
at lower SHBG concentrations (1 nM) 
(Figure 1B). This could have been tested 
by examining the percentage uptake of 
500 nM 125I-SHBG. Nevertheless, it is 
unlikely that the discrepancy between 
the uptake of 125I-SHBG and the uptake 
of 3H-testosterone can be attributed to 
a decreased percentage uptake of 125I-
SHBG because there is little change in 
3H-testosterone uptake as the SHBG 
concentration is increased from 10 to 
500 nM, or as the ratio of SHBG to tes-
tosterone is increased from 1:10 to 5:1. 
When the concentration of SHBG is 10 
nM and that of testosterone is 100 nM, 
then 99.9% of 3H-testosterone is free 
and about 10% of the added (100 nM) 
3H-testosterone is taken up by cells. 
When the percent of free 3H-testoster-
one is <0.5% (achieved by incubation 
of 500 nM SHBG with 100 nM 3H-tes-
tosterone), the same percentage (10%) 
of the added 3H-testosterone is taken 
up by cells. These observations are 
difficult to reconcile with a model that 
posits uptake of bound testosterone. 
Certainly, SHBG does not appear to be 
necessary for cellular uptake of testo-
sterone under these circumstances.
Hammes et al. (2005) also investigated 
uptake of the testosterone metabolite 
3H-dihydrotestosterone (DHT), a potent 
androgen in its own right, and of 3H-
estradiol in a keratinocyte cell line that 
does not express megalin (Figure 1F). 
They show about 1% uptake by the 
cells but again do not supply kinetic 
and chemical data. Others have shown 
that when the HaCaT keratinocyte cell 
line is incubated with 3H-testosterone 
in culture medium lacking SHBG, of 
the 93% of the 3H-label observed in 
the medium, only 7% of the 3H rep-
resents unmetabolized testosterone 
(Altenburger and Kissel, 1999). Thus, 
most of the testosterone must have 
entered the cell to be metabolized and 
then must have been secreted back 
into the medium. Hence, the finding ebruary 10, 2006 ©2006 Elsevier Inc. 455
by Hammes et al. that only about 1% 
of the 3H-label in their experiments is 
associated with the cells is difficult 
to interpret.
Although some of the experiments 
by Hammes et al. are consistent with 
their “bound steroid” hypothesis (see, 
for example, Figure 2A), others are not 
(for example, see Figures 2B and 2C). 
At a concentration of 1 nM DHT plus 1 
nM SHBG, 50% of the steroid exists in 
the free form. One nanomole of DHT-
SHBG and 1 nM DHT are equally effec-
tive at entering cells and activating an 
androgen-responsive reporter gene 
(Figure 2B); SHBG alone is about 25% 
as effective at activating the reporter 
gene as DHT alone. The most reason-
able interpretation is that free DHT is 
the active species and that SHBG itself 
has a modest effect (through mecha-
nisms not explained by these experi-
ments). RAP almost completely inhibits 
activation of the reporter gene by 1 nM 
DHT-SHBG, despite the fact that half of 
the DHT is unbound at this concentra-
tion. In contrast, 1 nM DHT alone is not 456 Cell 124, February 10, 2006 ©2006 E
In our study (Hammes et al., 2005), we 
set out to understand the role of meg-
alin, an endocytic receptor of the LDL 
receptor gene family, in reproductive 
tissues. We chose the most appropri-
ate experimental models available to 
us: a megalin knockout mouse and 
the BN16 cell line, which has been 
widely used to study megalin-medi-
ated endocytosis.
In the megalin knockout mouse, we 
showed that a deficiency in the megalin 
receptor resulted in the impaired devel-
opment of male and female reproduc-
tive tissues and in sex steroid insensitiv-
ity, implicating megalin in androgen and 
Response: 
cellular Uptak
Steroid Hormoblocked by RAP and yields the same 
increase in reporter gene activation as 
1 nM DHT-SHBG. It is clear that SHBG 
is not necessary for DHT to enter the 
cell and to activate the reporter gene.
Thus, the conclusion by Hammes 
et al. that there is a megalin-mediated 
endocytic pathway for the uptake of 
androgens and estrogens bound to 
their SHBG proteins does not seem 
to be sufficiently supported by the 
evidence presented.
Note
All percentages for free steroids are calculated 
from the law of mass action for steroid pro-
tein interactions using the equations set out by 
Sodergard et al. (1982). The dissociation con-
stants (Kd) used in the calculations are 1 nM 
for the binding of testosterone to SHBG, and 
0.5 nM for the binding of DHT to SHBG.
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estrogen action in vivo. In BN16 cells, 
we showed that megalin, an estab-
lished endocytic receptor for the carrier 
bound steroid hormone 25-hydroxyvi-
tamin D3, can mediate the uptake of sex 
steroids bound to physiological carriers 
such as sex hormone binding globulin 
(SHBG) and androgen binding protein. 
These findings suggest that sex ster-
oids not only enter cells by free diffu-
sion but may also use endocytic path-
ways to gain entry into certain target 
cells. Furthermore, these data provide 
a mechanistic basis that can explain 
the observed sex steroid insensitivity in 
the megalin-deficient mouse.
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Mol. Biol. 16, 801–810.Megalin knockout mice suffer from 
obstruction of the vaginal cavity in 
females and impaired descent of the 
testes in males, albeit at normal plasma 
levels of sex steroids (Table 1, page 
755 of Hammes et al., 2005). These 
phenotypes are reminiscent of those 
found in animals treated with andro-
gen and estrogen receptor antago-
nists (Hammes et al., 2005). Contrary 
to Dr. Rosner’s claim, this phenotype 
cannot be accounted for by vitamin 
D deficiency because animals lacking 
the vitamin D receptor exhibit very low 
levels of estrogens and, as a conse-
quence, show uterine hypoplasia and 
impaired sperm motility (Kinuta et al., 
2000), which are defects not seen in 
megalin knockout mice.
We agree that little SHBG is found in 
adult mouse plasma, suggesting that 
this carrier protein has little relevance 
for systemic transport of sex steroids 
in adult rodents; the situation may be 
different during development when 
